Ticker · held by 4 filers

BCRX

BIOCRYST PHARMACEUTICALS INC

All tracked filers currently holding BCRX, ranked by position size. Each row links through to the filer's full portfolio.

Total value held

$153.6M

Total shares

23,832,850

Filers holding

4 · 6 positions

Caveat

long only · 13F-eligible managers only

Filers holding BCRX

sorted by position size · click any filer to see their full portfolio

# Filer Class Shares Value (USD) % of port

1 BlackRock · Larry Fink COM 19,956,255 $123.3M 0.00%

2 Renaissance Technologies · Jim Simons (founder) COM 2,128,821 $16.6M 0.03%

3 Citadel Advisors · Ken Griffin COM 1,298,902 $10.1M 0.00%

4 Bridgewater Associates · Ray Dalio (founder) COM 235,572 $1.8M 0.01%

5 Citadel Advisors · Ken Griffin PUTCOM 131,700 $1.0M 0.00%

6 Citadel Advisors · Ken Griffin CALLCOM 81,600 $636.5K 0.00%

What this is

This page reverses the usual 13F view: instead of "what does Buffett hold," it answers "who holds NVDA?" Across the dozen tracked filers, all current 13F-disclosed holders of BCRX are listed, with the position size and what fraction of each filer's overall portfolio it represents.

Caveats: only the filers tracked here are included (~12 names) — not the whole 13F universe (~6,000 filers). Position values are at the most recent quarter-end, not current market price. Only long positions are visible; shorts and synthetics aren't.

v0.2 · 2026 · data via SEC EDGAR · CUSIP→ticker via OpenFIGI